Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated 23 min ago

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Filters
Type
Date
Clear

Latest

5,331 studies

  1. Pancreatic Intraductal Papillary Mucinous Neoplasm in a Carrier of a Reported Pathogenic BRCA2 Variant: Diagnostic Considerations and Management Using European and International Guidelines.
    Julio C Balderas-Ortega, Yoeli Escandon-Espinoza, Katia Lopez Garcia +1
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Diagnostic Performance of CBC-Derived Inflammatory Ratios (SII, NLR, PLR) for Identifying Biopsy-Proven Microscopic Gut Inflammation Despite Normal Endoscopy.
    Hamid Ahmad, Muhammad Muzammil Hussain, Aya Ibrihim +8
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC
  3. UPF1-mediated mRNA decay promotes melanoma tumorigenesis through miR-101-3p-dependent destabilization of NANOS1.
    Suman Lee, Jae-Won Yoon, Dayeon Woo +4
    International journal of biological sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  4. Radiotherapy Reprograms CCR8⁺ Regulatory T Cells via REL-NF-κB to Enforce Spatial Immune Exclusion in Hepatocellular Carcinoma.
    Huanliang Chen, Shuxuan Wang, Bufu Tang +5
    International journal of biological sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  5. Metabolic Barriers to Cancer Immunotherapy: Multiscale Mechanisms from Organelle Dysfunction to Organ-Specific Constraints.
    Zichen Gui, Xiaoyin Yuan, Xiaoping Chen +3
    International journal of biological sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  6. Exponentially weighted ensemble deep learning for histologic growth pattern classification in lung adenocarcinoma
    R. Korutla, M. N. Jain, T. M. Karkera +4
    medRxivPreprintCC BYFull textOncologymedRxiv
  7. MRI-informed active surveillance outcomes and dietary fibre acceptability: the Aberdeen experience
    D. Sescu, J. Zbikowski, J. S. Royle +2
    medRxivPreprintCC BYFull textOncologymedRxiv
  8. Laboratory-Developed NGS Panel for Characterization of Advanced Colorectal Cancer, Real-World Data from a Tertiary Referral Centre.
    Floriana Jessica Di Paola, Giulia Calafato, Thais Maloberti +9
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  9. Limitations in US Cancer Screening Rate Data and Opportunities to Improve Precision Prevention.
    Jody Hoyos, Elissa Quinn, Daryl Pritchard +4
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  10. SPINT2 Is Associated with Dual-Phenotype Hepatocellular Carcinoma and Aggressive Tumor Features.
    Jie Zhang, Minjun Li, Taixin Yang +5
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  11. O-GlcNAcylated TCF4 Drives Ferroptosis Resistance and Tumor-Associated Macrophage Infiltration to Promote Colorectal Cancer Liver Metastasis.
    Han Yang, Jinhao Yu, Dong Hou +6
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  12. Intravesical Allogeneic Platelet Concentrate for Refractory BK Virus-Associated Haemorrhagic Cystitis After Allogeneic Haematopoietic Stem Cell Transplantation.
    Ahmet Semih Güleser, Hasan Sami Göksoy, Zeynep Doğuşan +7
    Journal of clinical medicinePeer-reviewedCC BYFull textOncologyEurope PMC
  13. A ZIP-Active Tumor Cell State Defines an NRF2-Associated Ferroptosis-Resistant and Immune-Cold Transcriptional Program in Head and Neck Squamous Cell Carcinoma.
    Hideyuki Takahashi, Miho Uchida, Kaoru Takahashi +4
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  14. Effectiveness of Interventions for Reducing Loneliness Among Adult Cancer Survivors: A Systematic Review and Meta-Analysis.
    Celia Sánchez-Gómez, Alba Sánchez-Gil, Eduardo José Fernández-Rodríguez +6
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  15. Cancer Stigma, Distress, and Cancer Coping in Relation to the Quality of Life Among Patients with Lung Cancer: A Cross-Sectional Study.
    Ji-Yeon Pyo, Seungkyoung Yang
    Healthcare (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  16. Assessment of Health-Related Quality of Life in Gastric Cancer Patients: A Cross-Sectional Study in North-Eastern Kazakhstan.
    Zhamilya B Kassymbay, Saulesh A Apbassova, Arnakyzy Yerkezhan +2
    Healthcare (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  17. Long-read RNA sequencing identifies non-coding isoform switching as a regulator of cell fate
    Victoire Fort, Gabriel Khelifi, Ruicen He +11
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textOncologyPMCEurope PMC
  18. Bacterial profile and antibiotic susceptibility of bloodstream infections among infants, children, and adolescents undergoing treatment for acute leukemia
    Razan Zatarah, Tala Albdour, Alaa Assad +2
    PLOS OnePeer-reviewedCC BY 4.0Full textInfectious diseaseOncologyPLOS
  19. Perception of fall risk among cancer survivors receiving Radiotherapy/Chemotherapy in China: A latent profile analysis
    Hongkun Liu, Yuping Cheng, Lin Wang +3
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyPLOS
  20. Comparative evaluation of convolutional and transformer-based object detection models for brain tumor localization in MRI
    Farhan Naeem, Amara Haroon, Nasru Minallah +2
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyOncologyPLOS
  21. Waterpipe smoke condensate activates autophagy in non-tumorigenic lung epithelial cells: Implications for inflammation and stemness
    Rania F. Zaarour, Bilal Azakir, Ayda S. Mahmood +4
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  22. Post-Translational Modification Crosstalk in Gastric Cancer: Molecular Switches, Signaling Networks, and Therapeutic Opportunities, with Comparative Insights from Colorectal Cancer
    Jun Wang, Xianying Chen, Yu Wang +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  23. Association of Preoperative Circulating Hsp70 Levels with Event-Free Survival in Thoracic Oncology
    Dominik Lobinger, Nicholas Taylor, Verena Messner +7
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  24. Amivantamab plus chemotherapy vs. chemotherapy in participants with EGFR-mutant advanced non-small cell lung cancer after progression on osimertinib: a MARIPOSA-2 analysis of the Asian subgroup
    Jin-Yuan Shih, Jie Wang, Yongsheng Wang +15
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  25. Retrospective real-world associations between EGFR alterations and furmonertinib outcomes in advanced non-small cell lung cancer
    Yameng Cui, Shaozhang Zhou, Zheng Liu +9
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC